NINDS Exploratory/Developmental Projects in Translational Research (R21)
Funding Contact: NINDS Funding Coordinator
Funding Categories: Translational Research
Detailed Description: This Funding Opportunity Announcement (FOA) requests applications for projects intended to complete preliminary steps in the
pipeline for the pre-clinical development of therapeutics for neurological disorders. Such projects, if successful, should
lead directly to a subsequent project that will include all remaining activities for submission of an Investigational New
Drug (IND) or Investigational Device Exemptions (IDE) application to the Food and Drug Administration (FDA). Only Aims required
for therapy development can be supported in this program. This program excludes clinical research, basic research and studies
of disease mechanism. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.